Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

YOUNES A., BRODY J., CECİLİA C., LOPEZ A., YEHUDA D. B., FERHANOĞLU A. B., ...More

ASH 2017, 6 - 14 December 2017, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Ankara University Affiliated: Yes